4[1]Munafo A,Christen Y, Nussber J,et al. Drug concentration-response relationships in normal volunteers after oral administration of losartan, an angiotensinII receptor antagonist. Clin pharmacol Ther,1992;51:513～521.
5[2]Ribstein J, Picard A, Armagrac C, et al. Full antagonism of pressor response to exogenous angiotensin II(AII)by single dose irbsartan in normotensive subjects.J Hypertens,(Abstract)1997;15:S117.
6[3]Roberto F ,Annalisa Z , Amedeo M, et al. comparative efficacy of losartan and valosartan in mild-to-moderate hypertension results of 24-hour ambulatory blood Pressure monitoring current.Therapetic Research, 1999;49:195～206.
7[4]Mario MR,langenbacher KM,Fond NF,et al.Safety ,tolerability,pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.Clin pharmacol Ther, 1997;61:207.
8[5]Chrishen Y,Wacber B,Nussberger J,et al.Oral administration of Dup 753,a specific angiotensin II receptor antagonist ,to normal volunteers: inhibition of pressor response to exogenous angiotensin I and II. Circulation,1991;83:1333～1342.
9[6]Cazaubon C,Cougat J,Bousqute F,et al. Pharmacological characterization of SR 47436 ,a new nonpeptide ATI,subtype angiotensin (receptor antagonist). J Pharmacol Exp Ther,1993;265: 826～834.
10Amra SS, DongreN, Ballary C et al. Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: a pilot study. J Indian Med Assoe, 2003; 101 (5): 327～328
